Senseonics CEO and leadership

Tim Goodnow is the President and Chief Executive Officer at Senseonics, Inc. Tim joined the Senseonics Board of Directors in December 2010 and in March 2011 was named President & CEO. Tim has been instrumental in commercializing the first 90-day Eversense CGM System in Europe and the 180-day product - Eversense XL - which is now distributed in more than 15 countries. He also successfully launched Eversense in the U.S. only 40 days after FDA approval. Tim continues to drive innovation, product development and new technology for future CGM systems. Prior to Senseonics, Tim was Vice President of Technical Operations at Abbott Diabetes Care. He also held executive positions at TheraSense, Verax Biomedical, Dade Behring and Baxter Healthcare. Tim earned his PhD and Bachelor of Science degree in Chemistry at the University of Miami.

Nick Tressler is the Chief Financial Officer at Senseonics. Nick brings over 20 years of experience, strategic financial leadership and operational business partnering in the life sciences, biopharmaceutical and technology sectors. Nick previously was Vice President, Financial Planning and Analysis at Sucampo Pharmaceuticals, Inc., a public global biopharmaceutical company which was acquired by Mallinckrodt Pharmaceuticals for $1.2 billion in 2018. Prior to joining Sucampo, Nick was a Site Controller at AstraZeneca PLC, a public global biopharmaceutical company. Previously, Nick held various financial leadership roles at MedImmune LLC a biopharmaceutical company which was acquired by AstraZeneca in 2007 for $15.6 billion. Prior to MedImmune, Nick held finance roles at Corvis Corporation, an optical networking equipment maker that raised more than $1 billion in its Initial Public Offering (IPO) in 2000 and Honeywell International, a Fortune 500 company that produces commercial and consumer products, engineering services and aerospace systems. Nick holds a MBA from the Johns Hopkins University and a BS in Finance from the University of Maryland.

Dr. Francine R. Kaufman is the Chief Medical Officer at Senseonics, Inc. As Chief Medical Officer, Dr. Kaufman is dedicated to helping drive the innovation platform and the clinical value proposition of the Eversense CGM system. As one of the world’s leading endocrinologists, she brings a deep understanding of the global medical, research, and clinical diabetes community. Her track record of applying novel technologies to advance diabetes care for patients make her ideally suited for her role. Dr. Kaufman’s career spans almost 40 years in diabetes care. She is a dedicated pediatric endocrinologist and has served as director of the Comprehensive Childhood Diabetes Center, and head of the Center for Endocrinology, Diabetes and Metabolism at Children’s Hospital Los Angeles. Dr. Kaufman is also a Distinguished Professor Emerita of Pediatrics and Communications at the Keck School of Medicine and the Annenberg School of Communications of the University of Southern California. She was formerly the president of the American Diabetes Association, chair of the National Diabetes Education Program and elected to the National Academy of Medicine. She is the author of over 250 scientific manuscripts and numerous books, including Diabesity: The Obesity-Diabetes Epidemic That Threatens America and the ADA’s Insulin Pumps and Continuous Glucose Monitoring: A User’s Guide to Effective Diabetes Management. Dr. Kaufman is an active philanthropist working with numerous organizations and charities around the world aimed at improving the lives of people with diabetes. She was also an advisor to the Governor on the California Initiative on Health, Fitness and Obesity. Most recently Dr. Kaufman served as Chief Medical Officer and Vice President of Global Clinical, Regulatory and Medical Affairs at Medtronic Diabetes. Dr. Kaufman received a Bachelor of Arts degree from Northwestern University and was the Valedictorian of her class at Chicago Medical School.

Mukul Jain is the Chief Operating Officer at Senseonics, Inc. Mukul is responsible for overseeing Quality, Regulatory, Product Development and Global Operations - including manufacturing and supply chain. Prior to joining Senseonics, Mukul spent 13 years at Medtronic working on active implantable devices in CRDM and Neuromodulation space. He was responsible for managing the development of Neurostimulator systems in spinal cord stimulation and sacral nerve stimulation. Prior to that, he worked at Medtronic Energy and Components Center developing various critical components used across Medtronic’s implantable devices. Mukul earned his MBA from Carlson School of Management at the University of Minnesota, a PhD in chemical engineering from the University of South Carolina and a B.Tech. from Indian Institute of Technology, Kanpur.

Tim Goodnow is the President and Chief Executive Officer at Senseonics, Inc. Tim joined the Senseonics Board of Directors in December 2010 and in March 2011 was named President & CEO. Tim has been instrumental in commercializing the first 90-day Eversense CGM System in Europe and the 180-day product - Eversense XL - which is now distributed in more than 15 countries. He also successfully launched Eversense in the U.S. only 40 days after FDA approval. Tim continues to drive innovation, product development and new technology for future CGM systems. Prior to Senseonics, Tim was Vice President of Technical Operations at Abbott Diabetes Care. He also held executive positions at TheraSense, Verax Biomedical, Dade Behring and Baxter Healthcare. Tim earned his PhD and Bachelor of Science degree in Chemistry at the University of Miami.

Dr. Francine R. Kaufman is the Chief Medical Officer at Senseonics, Inc. As Chief Medical Officer, Dr. Kaufman is dedicated to helping drive the innovation platform and the clinical value proposition of the Eversense CGM system. As one of the world’s leading endocrinologists, she brings a deep understanding of the global medical, research, and clinical diabetes community. Her track record of applying novel technologies to advance diabetes care for patients make her ideally suited for her role. Dr. Kaufman’s career spans almost 40 years in diabetes care. She is a dedicated pediatric endocrinologist and has served as director of the Comprehensive Childhood Diabetes Center, and head of the Center for Endocrinology, Diabetes and Metabolism at Children’s Hospital Los Angeles. Dr. Kaufman is also a Distinguished Professor Emerita of Pediatrics and Communications at the Keck School of Medicine and the Annenberg School of Communications of the University of Southern California. She was formerly the president of the American Diabetes Association, chair of the National Diabetes Education Program and elected to the National Academy of Medicine. She is the author of over 250 scientific manuscripts and numerous books, including Diabesity: The Obesity-Diabetes Epidemic That Threatens America and the ADA’s Insulin Pumps and Continuous Glucose Monitoring: A User’s Guide to Effective Diabetes Management. Dr. Kaufman is an active philanthropist working with numerous organizations and charities around the world aimed at improving the lives of people with diabetes. She was also an advisor to the Governor on the California Initiative on Health, Fitness and Obesity. Most recently Dr. Kaufman served as Chief Medical Officer and Vice President of Global Clinical, Regulatory and Medical Affairs at Medtronic Diabetes. Dr. Kaufman received a Bachelor of Arts degree from Northwestern University and was the Valedictorian of her class at Chicago Medical School.